“Effectiveness and Safety Profile of Tofacitinib and Baricitinib in Rheumatoid Arthritis Patients: Results from a 24-Month Real-Life Prospective Study in Southern-Italy”. Reumatismo 74, no. 3 (December 29, 2022). Accessed May 22, 2025. https://www.reumatismo.org/reuma/article/view/1511.